These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1390205)

  • 1. Acute promyelocytic leukaemia.
    Avvisati G; ten Cate JW; Mandelli F
    Br J Haematol; 1992 Jul; 81(3):315-20. PubMed ID: 1390205
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral administration of arsenic trioxide in the treatment of acute promyelocytic leukaemia and accelerated phase chronic myeloid leukaemia: an Australian single-centre study.
    Firkin F
    Intern Med J; 2012 Aug; 42(8):948-52. PubMed ID: 22906029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell population data-driven acute promyelocytic leukaemia flagging through artificial neural network predictive modelling.
    Haider RZ; Shamsi T; Ujjan IU
    Clin Med (Lond); 2020 Mar; 20(Suppl 2):s28. PubMed ID: 32409353
    [No Abstract]   [Full Text] [Related]  

  • 4. Restitution of normal marrow morphology and karyotype in acute refractory acute promyelocytic leukaemia with all-trans retinoic acid.
    Creagh MD; Clark DJ; Collin RC
    Br J Haematol; 1991 Aug; 78(4):572. PubMed ID: 1911349
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical characteristics and treatment outcome of an 86-year-old patient with acute myeloid leukaemia with acute promyelocytic-like morphology and uncommon RARA fusion variant.
    Castelli R; Rossi V; Della Porta MG; Schiavon R; Barchiesi M; Cicconi L; Coco FL
    Ann Hematol; 2018 Dec; 97(12):2523-2525. PubMed ID: 29872883
    [No Abstract]   [Full Text] [Related]  

  • 6. The apparent excess of acute promyelocytic leukemia in infant acute leukemias in Brazil.
    Mendes WL; Coser VM; Ramos G; Pereira W; Lopes LF; de Oliveira MS
    Haematologica; 2004 Nov; 89(11):ELT16. PubMed ID: 15533849
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute promyelocytic leukaemia. Report of a meeting of Physicians and Scientists, University College London.
    Lancet; 1994 Dec; 344(8937):1615-8. PubMed ID: 7983997
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of acute promyelocytic leukaemia with unusual cytological features and a ZBTB16-RARA fusion gene.
    Lechevalier N; Dulucq S; Bidet A
    Br J Haematol; 2016 Aug; 174(4):502. PubMed ID: 27302179
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin therapy for acute leukaemia.
    van der Weyden MB; Curtis DJ; Szer J
    Aust N Z J Med; 1992 Oct; 22(5):446-8. PubMed ID: 1445033
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic research in untreated acute promyelocytic leukemia.
    Estey E
    Leukemia; 2005 Jun; 19(6):913-5. PubMed ID: 15843820
    [No Abstract]   [Full Text] [Related]  

  • 11. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraploidy with double t(15;17)(q22;q21) in acute promyelocytic leukaemia.
    Mohamed M; Dun K
    Pathology; 2013 Feb; 45(2):203-5. PubMed ID: 23250036
    [No Abstract]   [Full Text] [Related]  

  • 13. Clustered incidence of adult acute promyelocytic leukemia.
    Brunner AM; Kim PG; Sadrzadeh H; Drapkin BJ; Sprague KA; Sloan JM; Chai-Ho W; Bhargava P; Pozdnyakova O; Fathi AT
    Leuk Res; 2018 Nov; 74():47-50. PubMed ID: 30292128
    [No Abstract]   [Full Text] [Related]  

  • 14. Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia.
    Young CS; Clarke KM; Mills KI
    EBioMedicine; 2015 Jun; 2(6):487-8. PubMed ID: 26288810
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating acute promyelocytic leukaemia in Latin America: lessons from the International Consortium on Acute Leukaemia experience.
    Corrêa de Araujo Koury L; Ganser A; Berliner N; Rego EM
    Br J Haematol; 2017 Jun; 177(6):979-983. PubMed ID: 28466545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients.
    Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J
    Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spanish contributions to management of acute promyelocytic leukemia.
    Haematologica; 2001 Jun; 86(6):561-2. PubMed ID: 11418363
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute promyelocytic leukemia: from treatment to genetics and back.
    Kogan SC; Bishop JM
    Oncogene; 1999 Sep; 18(38):5261-7. PubMed ID: 10498878
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute promyelocytic leukemia in the west of Venezuela].
    De Salvo L; Weir Medina J; Gómez Sánchez O; de Baena ES; de Ramos BU; Guevara J; Luengo Vera J; de Vizcaíno MA; Sánchez H; de León E
    Sangre (Barc); 1989 Oct; 34(5):329-31. PubMed ID: 2617382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How acute promyelocytic leukaemia revived arsenic.
    Zhu J; Chen Z; Lallemand-Breitenbach V; de Thé H
    Nat Rev Cancer; 2002 Sep; 2(9):705-13. PubMed ID: 12209159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.